Triple Negative Breast Cancer (TNBC) has the highest mortality rate among all breast cancers due to shorter time to develop metastases and high recurrence rates. The inventors have uncovered a small molecule that exhibits selectivity toward TNBC cells while sparing normal surrounding cells.
The ClariMark test allows detection of early stage lung cancer at the point when it is most treatable. This test is a proprietary immunoassay on blood that screens for the presence of elevated levels of specific cancer biomarkers associated with an increased incidence of lung cancer. Clinical studies have demonstrated that blood levels of these […]
A Drug Therapy Utilizing the Alpha4 / Beta2 Receptor Target for the Treatment of Obsessive-Compulsive
Tandem Cytotoxic Drug Delivery & p53-Status-Independent Apoptosis Promotion.
LICENSED: Orally administered phenylalanine ammonia lyase microcapsules for the management of phenylketonuria (PKU).